bioRxivImmunology
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
A. Sokal, P. Chappert, A. Roeser, G. Barba-Spaeth, S. Fourati, I. Azzaoui, A. Vandenberghe, I. Fernandez, M. Bouvier-Alias, E. Crickx, A. Beldi Ferchiou, S. Hue, L. Languille, S. Baloul, F. Noizat-Pirenne, M. Luka, J. Megret, M. Menager, J.-M. Pawlotsky, S. Fillatreau, F. A. Rey, J.-C. Weill, C.-A. Reynaud, M. Mahevas
Abstract
Memory B cells play a fundamental role in host defenses against viruses, but to date, their role have been relatively unsettled in the context of SARS-CoV-2. We report here a longitudinal single-cell and repertoire profiling of the B cell response up to 6 months in mild and severe COVID-19 patients. Distinct SARS-CoV-2 Spike-specific activated B cell clones fueled an early antibody-secreting cell burst as well as a durable synchronous germinal center response. While highly mutated memory B cells, including preexisting cross-reactive seasonal Betacoronavirus-specific clones, were recruited early in the response, neutralizing SARS-CoV-2 RBD-specific clones accumulated with time and largely contributed to the late remarkably stable memory B-cell pool. Highlighting germinal center maturation, these cells displayed clear accumulation of somatic mutations in their variable region genes over time. Overall, these findings demonstrate that an antigen-driven activation persisted and matured up to 6 months after SARS-CoV-2 infection and may provide long-term protection.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: trajectory inference
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Evolution of Antibody Immunity to SARS-CoV-2
C. Gaebler, Z. Wang, … R. Patel·bioRxiv·Nov 3, 2020
- SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe disease
R. Reyes, K. Clarke, … E. M. Bunnik·bioRxiv·Sep 24, 2021
- Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
S. P. Anand, J. Prevost, … A. Finzi·bioRxiv·Jan 25, 2021
- Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
R. Marzi, J. Bassi, … L. Piccoli·bioRxiv·Sep 30, 2022
- Longitudinal characterization of humoral and cellular immunity in hospitalized COVID-19 patients reveal immune persistence up to 9 months after infection
J. T. Sandberg, R. Varnaite, … S. Gredmark-Russ·bioRxiv·Mar 17, 2021
- Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection
N. Sherina, A. Piralla, … Q. Pan-Hammarstrom·bioRxiv·Nov 6, 2020